Imaging EGFR and HER2 by PET and SPECT: a review.
作者： Emily B. Corcoran , Robert N. Hanson
DOI: 10.1002/MED.21299
关键词:
摘要: In an effort to discover a noninvasive method for predicting which cancer patients will benefit from therapy targeting the EGFR and HER2 proteins, large body of research has been conducted toward development PET SPECT imaging agents, selectively target these receptors. We provide general overview advances made HER2, detailing investigation agents ranging in size small molecules monoclonal antibodies.
sci-hub.se 参考文章(144)
Trastuzumab and breast cancer. The New England Journal of Medicine. ,vol. 345, pp. 995- 996 ,(2001) , 10.1056/NEJM200109273451312
Snythesis of [F-18]-ZD1839 as a PET Imaging Agent for Epidermal Growth Factor Receptors Journal of Labelled Compounds and Radiopharmaceuticals. ,vol. 46, ,(2003) , 10.1002/JLCR.750
Romain Bejot, Julian Goggi, Shebbrin S. Moonshi, Parasuraman Padmanabhan, Kishore K. Bhakoo, Aminooxy‐functionalized DOTA for radiolabeling of oxidized antibodies: evaluation of site‐specific 111In‐labeled trastuzumab Journal of Labelled Compounds and Radiopharmaceuticals. ,vol. 55, pp. 346- 353 ,(2012) , 10.1002/JLCR.2950
Jennifer L. Harris, Michael Stocum, Lisa Roberts, Chunsheng Jiang, Jessie Lin, Kam Sprott, Quest for the Ideal Cancer Biomarker: An Update on Progress in Capture and Characterization of Circulating Tumor Cells Drug Development Research. ,vol. 74, pp. 138- 147 ,(2013) , 10.1002/DDR.21072
Eskender Mume, Anna Orlova, Barbro Larsson, Ann-Sofie Nilsson, Fredrik Y. Nilsson, Stefan Sjöberg, Vladimir Tolmachev, Evaluation of ((4-Hydroxyphenyl)ethyl)maleimide for Site-Specific Radiobromination of Anti-HER2 Affibody Bioconjugate Chemistry. ,vol. 16, pp. 1547- 1555 ,(2005) , 10.1021/BC050056O
Yosef Yarden, Mark X. Sliwkowski, Untangling the ErbB signalling network Nature Reviews Molecular Cell Biology. ,vol. 2, pp. 127- 137 ,(2001) , 10.1038/35052073
Torun Engfeldt, Anna Orlova, Thuy Tran, Alexander Bruskin, Charles Widström, Amelie Eriksson Karlström, Vladimir Tolmachev, Imaging of HER2-expressing tumours using a synthetic Affibody molecule containing the 99mTc-chelating mercaptoacetyl-glycyl-glycyl-glycyl (MAG3) sequence European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 34, pp. 722- 733 ,(2007) , 10.1007/S00259-006-0266-4
James Cronin, Elizabeth McAdam, Antonios Danikas, Chris Tselepis, Paul Griffiths, John Baxter, Linzi Thomas, James Manson, Gareth Jenkins, Epidermal growth factor receptor (EGFR) is overexpressed in high-grade dysplasia and adenocarcinoma of the esophagus and may represent a biomarker of histological progression in Barrett's esophagus (BE). The American Journal of Gastroenterology. ,vol. 106, pp. 46- 56 ,(2011) , 10.1038/AJG.2010.433
Vladimir Tolmachev, Daniel Rosik, Helena Wållberg, Anna Sjöberg, Mattias Sandström, Monika Hansson, Anders Wennborg, Anna Orlova, Imaging of EGFR expression in murine xenografts using site-specifically labelled anti-EGFR 111In-DOTA-ZEGFR:2377 Affibody molecule: aspect of the injected tracer amount European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 37, pp. 613- 622 ,(2010) , 10.1007/S00259-009-1283-X
Vladimir Tolmachev, Irina Velikyan, Mattias Sandström, Anna Orlova, A HER2-binding Affibody molecule labelled with 68Ga for PET imaging: direct in vivo comparison with the 111In-labelled analogue. European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 37, pp. 1356- 1367 ,(2010) , 10.1007/S00259-009-1367-7